Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis

Paolo Amerio, Carlo Renè Girardelli, Gianluca Proietto, Pietro Forleo, Luca Cerritelli, Claudio Feliciani, Laura Colonna, Patrizia Teofoli, Pierluigi Amerio, Pietro Puddu, Damiano Abeni

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Dermatomyositis is an inflammatory myopathy characterized by proximal symmetrical muscle weakness with a characteristic cutaneous eruption. Population-based cohort studies provide evidence of an increased frequency of cancer in dermatomyositis patients. Many signs and serology tests have been suggested as markers for malignancy in dermatomyositis. We performed a case-control study on the patients admitted in our institutions for dermatomyositis. Clinical and laboratory data were collected and statistical analysis was performed to reveal important predictive signs of malignancy in dermatomyositis. We found no statistical difference in the clinical or laboratory parameters between the dermatomyositis patients with or without malignancy, with the exception of the erythrocyte sedimentation rate. In our study group an erythrocyte sedimentation rate higher than 35 mm/hr was very strongly associated with the presence or the development of a malignancy. Given the high positive and negative predictive values observed in our study, erythrocyte sedimentation rate evaluation using this cut-off point could be very useful in alerting dermatologists to the need for more in-depth diagnostic procedures in dermatomyositis patients.

Original languageEnglish
Pages (from-to)165-169
Number of pages5
JournalEuropean Journal of Dermatology
Volume12
Issue number2
Publication statusPublished - 2002

Fingerprint

Dermatomyositis
Blood Sedimentation
Tumor Biomarkers
Neoplasms
Myositis
Muscle Weakness
Serology
Case-Control Studies
Cohort Studies
Skin
Population

Keywords

  • Autoimmune disease
  • Cancer
  • Dermatomyositis
  • Diagnosis
  • Erythrocyte sedimentation rate

ASJC Scopus subject areas

  • Dermatology

Cite this

Amerio, P., Girardelli, C. R., Proietto, G., Forleo, P., Cerritelli, L., Feliciani, C., ... Abeni, D. (2002). Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis. European Journal of Dermatology, 12(2), 165-169.

Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis. / Amerio, Paolo; Girardelli, Carlo Renè; Proietto, Gianluca; Forleo, Pietro; Cerritelli, Luca; Feliciani, Claudio; Colonna, Laura; Teofoli, Patrizia; Amerio, Pierluigi; Puddu, Pietro; Abeni, Damiano.

In: European Journal of Dermatology, Vol. 12, No. 2, 2002, p. 165-169.

Research output: Contribution to journalArticle

Amerio, P, Girardelli, CR, Proietto, G, Forleo, P, Cerritelli, L, Feliciani, C, Colonna, L, Teofoli, P, Amerio, P, Puddu, P & Abeni, D 2002, 'Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis', European Journal of Dermatology, vol. 12, no. 2, pp. 165-169.
Amerio P, Girardelli CR, Proietto G, Forleo P, Cerritelli L, Feliciani C et al. Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis. European Journal of Dermatology. 2002;12(2):165-169.
Amerio, Paolo ; Girardelli, Carlo Renè ; Proietto, Gianluca ; Forleo, Pietro ; Cerritelli, Luca ; Feliciani, Claudio ; Colonna, Laura ; Teofoli, Patrizia ; Amerio, Pierluigi ; Puddu, Pietro ; Abeni, Damiano. / Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis. In: European Journal of Dermatology. 2002 ; Vol. 12, No. 2. pp. 165-169.
@article{76cd46ea164d4e358e1bc31d4897bbe4,
title = "Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis",
abstract = "Dermatomyositis is an inflammatory myopathy characterized by proximal symmetrical muscle weakness with a characteristic cutaneous eruption. Population-based cohort studies provide evidence of an increased frequency of cancer in dermatomyositis patients. Many signs and serology tests have been suggested as markers for malignancy in dermatomyositis. We performed a case-control study on the patients admitted in our institutions for dermatomyositis. Clinical and laboratory data were collected and statistical analysis was performed to reveal important predictive signs of malignancy in dermatomyositis. We found no statistical difference in the clinical or laboratory parameters between the dermatomyositis patients with or without malignancy, with the exception of the erythrocyte sedimentation rate. In our study group an erythrocyte sedimentation rate higher than 35 mm/hr was very strongly associated with the presence or the development of a malignancy. Given the high positive and negative predictive values observed in our study, erythrocyte sedimentation rate evaluation using this cut-off point could be very useful in alerting dermatologists to the need for more in-depth diagnostic procedures in dermatomyositis patients.",
keywords = "Autoimmune disease, Cancer, Dermatomyositis, Diagnosis, Erythrocyte sedimentation rate",
author = "Paolo Amerio and Girardelli, {Carlo Ren{\`e}} and Gianluca Proietto and Pietro Forleo and Luca Cerritelli and Claudio Feliciani and Laura Colonna and Patrizia Teofoli and Pierluigi Amerio and Pietro Puddu and Damiano Abeni",
year = "2002",
language = "English",
volume = "12",
pages = "165--169",
journal = "European Journal of Dermatology",
issn = "1167-1122",
publisher = "NLM (Medline)",
number = "2",

}

TY - JOUR

T1 - Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis

AU - Amerio, Paolo

AU - Girardelli, Carlo Renè

AU - Proietto, Gianluca

AU - Forleo, Pietro

AU - Cerritelli, Luca

AU - Feliciani, Claudio

AU - Colonna, Laura

AU - Teofoli, Patrizia

AU - Amerio, Pierluigi

AU - Puddu, Pietro

AU - Abeni, Damiano

PY - 2002

Y1 - 2002

N2 - Dermatomyositis is an inflammatory myopathy characterized by proximal symmetrical muscle weakness with a characteristic cutaneous eruption. Population-based cohort studies provide evidence of an increased frequency of cancer in dermatomyositis patients. Many signs and serology tests have been suggested as markers for malignancy in dermatomyositis. We performed a case-control study on the patients admitted in our institutions for dermatomyositis. Clinical and laboratory data were collected and statistical analysis was performed to reveal important predictive signs of malignancy in dermatomyositis. We found no statistical difference in the clinical or laboratory parameters between the dermatomyositis patients with or without malignancy, with the exception of the erythrocyte sedimentation rate. In our study group an erythrocyte sedimentation rate higher than 35 mm/hr was very strongly associated with the presence or the development of a malignancy. Given the high positive and negative predictive values observed in our study, erythrocyte sedimentation rate evaluation using this cut-off point could be very useful in alerting dermatologists to the need for more in-depth diagnostic procedures in dermatomyositis patients.

AB - Dermatomyositis is an inflammatory myopathy characterized by proximal symmetrical muscle weakness with a characteristic cutaneous eruption. Population-based cohort studies provide evidence of an increased frequency of cancer in dermatomyositis patients. Many signs and serology tests have been suggested as markers for malignancy in dermatomyositis. We performed a case-control study on the patients admitted in our institutions for dermatomyositis. Clinical and laboratory data were collected and statistical analysis was performed to reveal important predictive signs of malignancy in dermatomyositis. We found no statistical difference in the clinical or laboratory parameters between the dermatomyositis patients with or without malignancy, with the exception of the erythrocyte sedimentation rate. In our study group an erythrocyte sedimentation rate higher than 35 mm/hr was very strongly associated with the presence or the development of a malignancy. Given the high positive and negative predictive values observed in our study, erythrocyte sedimentation rate evaluation using this cut-off point could be very useful in alerting dermatologists to the need for more in-depth diagnostic procedures in dermatomyositis patients.

KW - Autoimmune disease

KW - Cancer

KW - Dermatomyositis

KW - Diagnosis

KW - Erythrocyte sedimentation rate

UR - http://www.scopus.com/inward/record.url?scp=0036188218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036188218&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 165

EP - 169

JO - European Journal of Dermatology

JF - European Journal of Dermatology

SN - 1167-1122

IS - 2

ER -